Friday, July 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 18 of 200 · By data quality, then INN

  1. fostamatinib disodium

    TAVALISSE RIGEL PHARMACEUTICALS INC

    ORAL FDA: approved

  2. fremanezumab

    AJOVY Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    N02CD03

  3. fremanezumab-vfrm

    AJOVY Teva Pharma GmbH

    INJECTION FDA: approved

  4. frovatriptan succinate

    FROVATRIPTAN SUCCINATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  5. fruquintinib

    FRUZAQLA Takeda

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    L01EK

  6. fulvestrant

    FULVESTRANT ACCORD Lacuna Pharma Pty Ltd

    INTRAMUSCULAR FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L02BA03

  7. furosemide

    APO-FRUSEMIDE Alphapharm Pty Ltd

    INJECTION FDA: approved · EMA: unknown · TGA: approved

    C03CA01

  8. gabapentin

    APX-GABAPENTIN Viatris Pharmaceuticals Co.,

    ORAL FDA: approved · TGA: approved

  9. gallium ga-68 gozetotide

    ILLUCCIX Telix Innovations

    INTRAVENOUS FDA: approved

  10. galsulfase

    NAGLAZYME BioMarin Pharmaceutical Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved

    A16AB

  11. ganciclovir sodium

    GANCICLOVIR SODIUM Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  12. ganirelix acetate

    FYREMADEL Amphastar France Pharmaceuticals

    INJECTION FDA: approved

  13. gemcitabine

    DBL GEMCITABINE INJECTION Pfizer Australia Pty Ltd

    INJECTION FDA: approved · TGA: approved · NMPA: clinical trials

  14. gemcitabine hydrochloride

    GEMCITABINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  15. gemfibrozil

    LOPID Teva Pharma GmbH

    ORAL FDA: approved

  16. gentamicin sulfate

    GENTAMICIN SULFATE Teva Pharma GmbH

    OPHTHALMIC FDA: approved

  17. givosiran

    GIVLAARI Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    A16AX16

  18. givosiran sodium

    GIVLAARI Alnylam Netherlands B.V.

    SUBCUTANEOUS FDA: approved

  19. glatiramer acetate

    COPAXONE Lacuna Pharma Pty Ltd

    SUBCUTANEOUS FDA: approved · TGA: approved

  20. glimepiride

    ARX-GLIMEPIRIDE Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

  21. glipizide

    MELIZIDE Pfizer Australia Pty Ltd

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  22. glucagon

    BAQSIMI Amphastar France Pharmaceuticals

    INTRAVENOUS FDA: approved · EMA: approved

    H04AA01

  23. glyburide

    GLUCOVANCE Teva Pharma GmbH

    ORAL FDA: approved · NMPA: clinical trials

  24. glycerol phenylbutyrate

    RAVICTI Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    A16AX09

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.